FDA Drug Application (021285) for TRILEPTAL by NOVARTIS

Back to FDA Applications sponsored by NOVARTIS

Application Number021285
Product Number001
FormSUSPENSION;ORAL
Dosage300MG/5ML
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameTRILEPTAL
Active IngredientOXCARBAZEPINE

Active IngredientCount
List of drugs with Active Ingredient OXCARBAZEPINE3


Back to FDA Applications sponsored by NOVARTIS